跳至主要内容
临床试验/DRKS00032619
DRKS00032619招募中Unknown

Pragmatic randomized controlled study to evaluate the clinical and biological effectiveness of the Parkinson's Disease Multimodal Complex Treatment (ProACT) - ProACT

niversitätsklinik für Neurologie der Ruhr-Universität Bochum am St. Josef-Hospital Bochum0 个研究点目标入组 114 人开始时间: 2023年9月13日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Majority (minimum age of 18 years)
  • 2. Ability to be informed
  • 3. Ability to consent
  • 4. Diagnosis of at least probable PD according to the Diagnostic Criteria of the Movement Disorder Society (Postuma et al., 2015)
  • 5. Modified disease stage according to Hoehn and Yahr (HY) of 1-4
  • 6. Presence of an elective indication for PD-MCT
  • 7. Place on the hospital's internal PKT waiting list that is more than seven months in the future

排除标准

  • 1. Diagnosis of atypical or symptomatic Parkinsonian syndrome
  • 2. Presence of a non-elective indication for PD-MCT
  • 3. Severe dementia or psychotic syndrome as assessed by the investigator
  • 4. Difficulties in meeting the study requirements
  • 5. Logistical reasons

研究者

发起方
niversitätsklinik für Neurologie der Ruhr-Universität Bochum am St. Josef-Hospital Bochum

相似试验